INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE)

Historical Holders from Q1 2016 to Q4 2025

Type / Class
Equity / BIOTECHNOLOGY
Symbol
PBE
Price per share
$82.15
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
978,161
Holdings value
$68,443,763
% of all portfolios
0%
Share change
-297,423
Value change
-$20,741,981
Average buys %
+0%
Average sells %
-0%
Number of holders
98
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
As of 30 Sep 2025, INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) has 98 institutional shareholders filing 13F forms. They hold 978,161 shares .

Institutional Holders of INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 11,575 $959,630 +$245,018 $82.15 4
2025 Q3 978,161 $68,443,763 -$20,741,981 $69.87 98
2025 Q2 1,279,367 $82,042,365 -$2,862,018 $64.10 95
2025 Q1 1,323,152 $83,927,905 -$175,979 $63.44 95
2024 Q4 1,326,022 $88,260,503 +$867,793 $66.53 97
2024 Q3 1,322,938 $92,410,456 -$7,574,963 $69.82 103
2024 Q2 1,423,568 $92,271,001 +$14,972,145 $64.81 100
2024 Q1 1,201,145 $77,685,792 -$13,859,542 $64.72 101
2023 Q4 1,200,100 $79,018,098 +$7,608,470 $65.84 95
2023 Q3 1,295,402 $73,895,313 -$283,849 $57.04 96
2023 Q2 1,302,175 $79,837,312 +$58,835 $61.29 97
2023 Q1 1,291,721 $81,080,858 +$5,184,618 $62.77 101
2022 Q4 1,212,633 $77,018,370 +$6,484,805 $63.50 103
2022 Q3 1,105,133 $65,142,145 -$3,370,422 $58.94 85
2022 Q2 1,091,048 $63,008,282 +$10,620,634 $57.74 85
2022 Q1 910,188 $56,421,786 -$8,928,314 $62.01 86
2021 Q4 1,082,157 $77,062,024 +$6,820,182 $71.21 99
2021 Q3 973,841 $72,916,745 +$4,475,875 $74.85 96
2021 Q2 908,416 $70,221,116 +$1,401,390 $77.33 93
2021 Q1 890,865 $64,249,163 +$102,795 $73.82 87
2020 Q4 862,753 $60,558,549 -$3,846,633 $70.13 79
2020 Q3 924,537 $52,457,488 +$730,117 $56.62 70
2020 Q2 909,544 $53,049,217 -$1,578,571 $58.27 74
2020 Q1 975,538 $45,554,572 -$4,876,335 $46.50 72
2019 Q4 1,102,338 $61,422,888 -$7,787,450 $55.85 75
2019 Q3 1,206,844 $57,132,948 -$1,297,503 $47.37 70
2019 Q2 1,235,172 $66,066,408 -$12,704,520 $53.51 76
2019 Q1 1,463,426 $80,670,762 -$5,591,400 $55.18 76
2018 Q4 1,604,631 $75,704,298 +$1,970,607 $47.07 69
2018 Q3 1,568,125 $93,163,101 +$35,721,803 $59.45 69
2018 Q2 917,622 $50,276,665 +$50,276,668 $54.71 67
2016 Q1 1,603 $90,000 $0 $56.14 1